In focus · trending topic

RNA therapeutics

14 stories · following the connections

ProQR Provides Enrollment Update on QR-110 Clinical Trial and Highlights Ophthalmology Presentations at ARVO

By Nasdaq OMXApr 23, 2018, 11:00 AM UTC

ProQR to Present at Two Upcoming Conferences

By Nasdaq OMXApr 3, 2018, 11:00 AM UTC

ProQR to Present at Upcoming Scientific Meeting and Investor Conference

By Nasdaq OMXFeb 6, 2018, 12:00 PM UTC

ProQR Receives Orphan Drug Designation from EMA for Drug Candidate QR-313 for Dystrophic Epidermolysis Bullosa

By Nasdaq OMXNov 29, 2017, 12:00 PM UTC

ProQR to Present at the Annual Piper Jaffray Healthcare Conference

By Nasdaq OMXNov 21, 2017, 12:00 PM UTC

ProQR Doses First LCA 10 Patient in Clinical Trial of QR-110, ProQR’s Lead Program for Genetic Blindness

By Nasdaq OMXNov 13, 2017, 12:00 PM UTC

ProQR Appoints Thaddeus Dryja, M.D. to Scientific Advisory Board

By Nasdaq OMXNov 9, 2017, 12:01 PM UTC

ProQR to Present at EuroTIDES Conference

By Nasdaq OMXOct 31, 2017, 11:00 AM UTC